T-lymphoblastic lymphoma
Conditions
Interventions
Tandem autologous peripheral blood stem cells transplant:Tandem autologous peripheral blood stem cells transplant
peripheral blood stem cells transplant:peripheral blood stem cells transplant
Sponsors
Xinqiao Hospital, Third Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. New diagnosis of T-LBL phase III/IV, after the early induction treatment efficacy evaluation CR/PR; 2. Male and female aged between 18 and 60 years old; 3. KPS >60score estimated survival tiem less than 6 months; 4. No serious systemic organ dysfunction; 5. Able and willing to provide signed informed consent.
Exclusion criteria
Exclusion criteria: 1) With severe cardiac, renal or liver dysfunction; 2) Combined with other malignancies require treatment; 3) The clinical symptoms of brain dysfunction or severe mental illness can not understand or follow the research program; 4) Complete treatment planning and follow-up observation of patients cannot be guaranteed; 5) Patients taking part in other clinical trials; 6) Researchers believe other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete remission;overall survival;progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication of transplant;relapse remission; | — |
Countries
China
Contacts
Public ContactLiu YAO
Center of Hematology, Xinqiao Hospital, Third Military Medical University
Outcome results
None listed